Similar Search Results

The generics paradox revisited : empirical evidence from regulated markets

Vandoros, Sotiris; Kanavos, Panos - In: Applied economics 45 (2013) 22/24, pp. 3230-3239

Persistent link: https://www.econbiz.de/10010345456

Profit-seeking behavior of medical providers and generic competition in the pharmaceutical market : evidence from Taiwan

Liu, Ya Ming; Hsieh, Chee-Ruey - In: The B.E. journal of economic analysis & policy 14 (2014) 1, pp. 241-275

Persistent link: https://www.econbiz.de/10010345585

Evaluating the US pharmaceutical patent policy

Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021

The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...

Persistent link: https://www.econbiz.de/10012802183

On the effect of parallel trade on manufacturers' and retailers' profits in the pharmaceutical sector

Dubois, Pierre; Sæthre, Morten - 2018

Persistent link: https://www.econbiz.de/10012267512

Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market

Bokhari, Farasat A. S.; Yan, Weijie - 2020

pharmaceuticals to examine how incumbents respond to change in the threat of entry. In line with the entry deterrence motive …

Persistent link: https://www.econbiz.de/10012285099

Outcome-based pricing for new pharmaceuticals via rebates

Adida, Elodie - In: Management science : journal of the Institute for … 67 (2021) 2, pp. 892-913

Persistent link: https://www.econbiz.de/10012505303

Extended producer responsibility for pharmaceuticals

Alev, Işıl; Atasu, Atalay; Toktay, L. Beril; Zhang, Can - In: Manufacturing & service operations management : M & SOM 24 (2022) 1, pp. 524-541

Persistent link: https://www.econbiz.de/10012818777

Product patents and access to innovative medicines in a post-trips-era

Watal, Jayashree; Dai, Rong - 2019 - Manuscript date: 28 March 2019

This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era … the introduction of product patents in pharmaceuticals affect the likelihood of pharmaceutical firms to launch new and … finds that introduction of product patent for pharmaceuticals in the patent law has a positive effect on launch likelihood …

Persistent link: https://www.econbiz.de/10011992779

Patents, trade and medicines : past, present and future

Shadlen, Kenneth C.; Sampat, Bhaven N.; Kapczynski, Amy - In: Review of international political economy 27 (2020) 1, pp. 75-97

Persistent link: https://www.econbiz.de/10012208081

Umbrella branding in pharmaceutical markets

Suppliet, Moritz - 2017

Persistent link: https://www.econbiz.de/10011734578